Dynamic Cell Therapies, founded in 2016, develops controllable CAR T cells for treating cancer. They use small molecule-antibody conjugates to bind tumor cells, so they can be recognized and killed by CAR T cells. Titrated dosing maximizes the treatment’s effectiveness in killing cancer cells, while keeping toxicity low. Current indications in their pipeline include Multiple Myeloma and Acute Myeloid Leukemia. Dynamic Cell Therapies was founded by Fred Mermelstein and is located in Watertown, Massachusetts.

Dynamic Cell Therapies

Founded: 2020
Location: Watertown, MA
Employee range: 11 - 50
Clinical stage: Clin0
Therapy area: Multiple Myeloma
Drug types: ONC
Lead product: DCT-CAR100

Drug notes:

About:

Jobs: